These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10484370)

  • 1. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.
    Rebrin K; Steil GM; van Antwerp WP; Mastrototaro JJ
    Am J Physiol; 1999 Sep; 277(3):E561-71. PubMed ID: 10484370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia.
    Steil GM; Rebrin K; Hariri F; Jinagonda S; Tadros S; Darwin C; Saad MF
    Diabetologia; 2005 Sep; 48(9):1833-40. PubMed ID: 16001232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself.
    Voskanyan G; Barry Keenan D; Mastrototaro JJ; Steil GM
    J Diabetes Sci Technol; 2007 Sep; 1(5):639-44. PubMed ID: 19885132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can interstitial glucose assessment replace blood glucose measurements?
    Rebrin K; Steil GM
    Diabetes Technol Ther; 2000; 2(3):461-72. PubMed ID: 11467349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.
    Rebrin K; Sheppard NF; Steil GM
    J Diabetes Sci Technol; 2010 Sep; 4(5):1087-98. PubMed ID: 20920428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of prolonged hyperglycemia on in vivo and in vitro insulin secretion in rats.
    Laury MC; Takao F; Bailbe D; Penicaud L; Portha B; Picon L; Ktorza A
    Endocrinology; 1991 May; 128(5):2526-33. PubMed ID: 2019264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular glucose distribution is not altered by insulin: analysis of plasma and interstitial L-glucose kinetics.
    Steil GM; Richey J; Kim JK; Wi JK; Rebrin K; Bergman RN; Youn JH
    Am J Physiol; 1996 Nov; 271(5 Pt 1):E855-64. PubMed ID: 8944672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin enhances glucose-induced insulin secretion in scheduled meal-fed sheep.
    Takahashi H; Kurose Y; Kobayashi S; Sugino T; Kojima M; Kangawa K; Hasegawa Y; Terashima Y
    J Endocrinol; 2006 Apr; 189(1):67-75. PubMed ID: 16614382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp.
    Mitrakou A; Vuorinen-Markkola H; Raptis G; Toft I; Mokan M; Strumph P; Pimenta W; Veneman T; Jenssen T; Bolli G
    J Clin Endocrinol Metab; 1992 Aug; 75(2):379-82. PubMed ID: 1639939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I inhibits glucose-stimulated insulin secretion but does not impair glucose metabolism in normal humans.
    Rennert NJ; Caprio S; Sherwin RS
    J Clin Endocrinol Metab; 1993 Mar; 76(3):804-6. PubMed ID: 8445040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.
    Rave K; Sidharta PN; Dingemanse J; Heinemann L; Roggen K
    Diabetes Technol Ther; 2010 Feb; 12(2):117-23. PubMed ID: 20105041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
    Luzi L; DeFronzo RA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process.
    Steil GM; Ader M; Moore DM; Rebrin K; Bergman RN
    J Clin Invest; 1996 Mar; 97(6):1497-503. PubMed ID: 8617883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels.
    Mitragotri S; Coleman M; Kost J; Langer R
    J Appl Physiol (1985); 2000 Sep; 89(3):961-6. PubMed ID: 10956339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring in interstitial fluid using glucose oxidase-based sensor compared to established blood glucose measurement in rats.
    Woderer S; Henninger N; Garthe CD; Kloetzer HM; Hajnsek M; Kamecke U; Gretz N; Kraenzlin B; Pill J
    Anal Chim Acta; 2007 Jan; 581(1):7-12. PubMed ID: 17386418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog.
    Barrett EJ; Schwartz RG; Francis CK; Zaret BL
    J Clin Invest; 1984 Sep; 74(3):1073-9. PubMed ID: 6381537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo insulin secretion and action in hyperglycemic rat.
    Laury MC; Penicaud L; Ktorza A; Benhaiem H; Bihoreau MT; Picon L
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E180-4. PubMed ID: 2669513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modest hyperglycemia prevents interstitial dispersion of insulin in skeletal muscle.
    Kolka CM; Castro AV; Kirkman EL; Bergman RN
    Metabolism; 2015 Feb; 64(2):330-7. PubMed ID: 25468139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.